Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I first-in-human DDvax vaccine study in healthy adults
PACTR202607634582899Phase 1Not yet recruiting
- Sponsor
- One Health Institute
- Start
- Nov 2026
- Countries
- 1
01
Overview
Phase 1 trial in Rift Valley fever (RVF), sponsored by One Health Institute. Primary endpoint: Safety and tolerability of DDvax. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
Rift Valley fever (RVF)
Beyond the preview
Go deeper on PACTR202607634582899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607634582899.